Use of Clinical and Intermediate Phenotypes to Assess Response to Quetiapine: the Role of Putative Causative Genes.
Phase of Trial: Phase IV
Latest Information Update: 16 May 2016
At a glance
- Drugs Quetiapine (Primary)
- Indications Schizophrenia
- Focus Pharmacogenomic; Therapeutic Use
- 10 Jun 2017 Biomarkers information updated
- 12 May 2016 Status changed from discontinued to completed.
- 23 Jun 2012 Status changed from suspended to discontinued as reported by European Clinical Trials Database.